- Sections
- C - Chimiemétallurgie
- C07H - Sucresleurs dérivésnucléosidesnucléotidesacides nucléiques
- C07H 11/04 - PhosphatesPhosphitesPolyphosphates
Détention brevets de la classe C07H 11/04
Brevets de cette classe: 137
Historique des publications depuis 10 ans
|
7
|
12
|
7
|
9
|
5
|
4
|
7
|
4
|
8
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Gilead Sciences, Inc. | 2183 |
8 |
| The Governing Council of The University of Toronto, | 1534 |
8 |
| Metro International Biotech, LLC | 40 |
8 |
| National Research Council of Canada | 1542 |
6 |
| University of Maryland, Baltimore | 1048 |
4 |
| Centre National de La Recherche Scientifique | 10865 |
3 |
| The Brigham and Women's Hospital, Inc. | 2258 |
3 |
| Glycomine, Inc. | 12 |
3 |
| Glytech, Inc. | 62 |
3 |
| Immune Design Corp. | 36 |
3 |
| Isis Innovation Limited | 458 |
3 |
| Rijksuniversiteit Groningen | 309 |
3 |
| BASF SE | 21113 |
2 |
| The United States of America as represented by the Secretary of the Navy | 2837 |
2 |
| President and Fellows of Harvard College | 6040 |
2 |
| Duke University | 3161 |
2 |
| Eth Zurich | 1311 |
2 |
| GlycoVaxyn AG | 15 |
2 |
| Horizon Technology Finance Corporation | 22 |
2 |
| University of Georgia Research Foundation, Inc. | 1059 |
2 |
| Autres propriétaires | 66 |